期刊文献+

应用非变性聚丙烯凝胶电泳筛选siRNA质粒的实验研究

Screening of siRNA expression plasmid by nondenaturing polyacrylamide gel electrophoresis
下载PDF
导出
摘要 目的探讨利用非变性聚丙烯凝胶电泳筛选TGF-β1特异性siRNA表达质粒。方法以高表达TGF—β1人肺腺癌细胞株A549为肿瘤细胞模型。应用Angela原则选择siRNA序列,12%非变性聚丙烯凝胶电泳筛选siRNA表达质粒并经测序后转染A549细胞,间接免疫荧光和免疫印迹法检测转染前后A549细胞中TGF-β1表达水平。结果经典分子克隆方法成功构建pOligo1210、pOligo1216、pOligo1363。12%非变性聚丙烯凝胶可以清晰地分辨出被双酶切的插入片段。转染A549细胞后均产生特异性的表达抑制效应,抑制率为50%~83.2%。结论采用非变性聚丙烯凝胶电泳成功筛选出TGF—β1为靶点的siRNA表达质粒,并可广泛应用于筛选siRNA质粒。 Objective To screen TGF-β1 specific siRNA expression plasmid by nondenaturing polyacrylamide gel electrophoresis. Methods Human lung adenocarcinoma A549 as tumor cell model, siRNA sequences were selected by Angela principle and siR NA plasmids were screened by nondenaturing polyacrylamide gel electrophoresis. Then A549 cells were transfected with the re formed plasmids. The expression level of TGF-β1 were detected by indirect immunofluorescence assay(IFA) and Western blotting. Results POligo 1210,pOligo 1216,pOligo 1363 TGF-β1 were constructed successfully. The insert sequence can be distinguished in 12% nondenaturing polyacrylamide gel electrophoresis. SiRNA plasmids were screened by nondenaturing polyacrylamide gel clectrophoresis successfully. TGF-β1 expression can be inhibited with three plasmids ranged from 50% to 83.2 %. Conclusion TGF-β1 specific siRNA plasmids were screened by nondenaturing polyacrylamide gel electrophoresis successfully, It will be helpful to the study of TGF-β1 in tumor cells.
出处 《重庆医学》 CAS CSCD 2006年第1期23-25,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30400440) 第三军医大学博士创新基金资助项目(20050030)
关键词 RNAI TGF-Β1 非变性聚丙烯凝胶电泳 RNAi TGF-β1 nondenaturing polyacrylamide gel electrophoresis
  • 相关文献

参考文献10

  • 1Hannon GJ. RNA interference[J]. Nature, 2002,418(4):244.
  • 2Gitlin L, Andino R. Nucleic acid-based immune system:the antiviral potential of mammalian RNA silencing[J]. J Virology, 2003,77(3): 7159.
  • 3Angela R, Devin L, Queta B, et al. Rational siRNA design for RNA interference[J]. Nat Biotechnol,2004, 22(4): 326.
  • 4Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001, 411(5): 494.
  • 5Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs[J]. Proc Natl Acad Sci USA, 2003,100(12):2014.
  • 6Castanotto D, Li H, Rossi JJ. Functional siRNA expression from transfected PCR products[J]. RNA,2002,8(12):1454.
  • 7羊正纲,陈智,徐宁,倪勤,潘修成,金晗英,李敏伟.载体法筛选乙型肝炎病毒S基因小干扰RNA靶位体系的建立[J].中华肝脏病杂志,2004,12(9):515-518. 被引量:4
  • 8蹇锐,程小星,安静,陈炜,王嘉丽,张俊磊,万颖杰,陈宗涛.应用载体介导的RNAi技术抑制Bcl-2的表达[J].第三军医大学学报,2004,26(4):294-297. 被引量:7
  • 9J.萨姆布鲁克 E.F.弗里奇 T.曼尼阿蒂斯 金冬雁 黎孟枫译.分子克隆实验指南[M].北京:科学出版社,1992.954-964.
  • 10唐华,张才全.胃癌TGF-β1蛋白表达及与细胞增殖和血管生成的关系[J].重庆医学,2004,33(7):1020-1022. 被引量:7

二级参考文献37

  • 1[1]Hannon G L. RNA interference[J]. Nature, 2002, 418(6894): 244-251.
  • 2[2]Jiang M, Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells[J]. Genes & Development, 2003, 17(7): 832-837.
  • 3[3]Cioca D P, Aoki Y, Kiyosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines[J]. Cancer Gene Therapy, 2003, 10(2): 125-133.
  • 4[4]Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science, 2002, 296(5567): 550-553.
  • 5[5]Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells[J]. Nat Biotechnol, 2002, 20(5): 497-500.
  • 6[6]Tuschl T. Expanding small RNA interference[J]. Nat Biotechnol, 2002, 20(5): 446-448.
  • 7[7]Elbashir S M, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs[J]. Methods, 2002, 26(2): 199-213.
  • 8[8]Zhang L, Yang N, Mohamed-Hadley A, et al. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J]. Biochem Biophys Res Commun, 2003, 303(4): 1169-1178.
  • 9[9]Cory S, Vaux D L, Strasser A, et al. Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation[J]. Cancer Res, 1999, 59(7 Suppl): 1685s-1692s.
  • 10[10]Schmitt C A, Rosenthal C T, Lowe S W. Genetic analysis of chemoresistance in primary murine lymphomas[J]. Nat Med, 2000, 6(9): 1029-1035.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部